标题
Respiratory Syncytial Virus: Current Progress in Vaccine Development
作者
关键词
-
出版物
Viruses-Basel
Volume 5, Issue 2, Pages 577-594
出版商
MDPI AG
发表日期
2013-02-06
DOI
10.3390/v5020577
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Challenges in developing a pediatric RSV vaccine
- (2014) Jeanne H. Schickli et al. Human vaccines & immunotherapeutics
- Reduced Frequencies and Heightened CD103 Expression among Virus-Induced CD8+T Cells in the Respiratory Tract Airways of Vitamin A-Deficient Mice
- (2012) Rajeev Rudraraju et al. Clinical and Vaccine Immunology
- Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993–2008
- (2012) Hong Zhou et al. CLINICAL INFECTIOUS DISEASES
- Respiratory Syncytial Virus Modified by Deletions of the NS2 Gene and Amino Acid S1313 of the L Polymerase Protein Is a Temperature-Sensitive, Live-Attenuated Vaccine Candidate That Is Phenotypically Stable at Physiological Temperature
- (2012) C. Luongo et al. JOURNAL OF VIROLOGY
- Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice
- (2012) Tobias Kamphuis et al. PLoS One
- Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats
- (2012) Gale Smith et al. PLoS One
- Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles
- (2012) S. Garlapati et al. VACCINE
- Vitamin A Deficiency Disrupts Vaccine-Induced Antibody-Forming Cells and the Balance of IgA/IgG Isotypes in the Upper and Lower Respiratory Tract
- (2012) Sherri L. Surman et al. VIRAL IMMUNOLOGY
- Nonclinical phenotypic and genotypic analyses of a Phase 1 pediatric respiratory syncytial virus vaccine candidate MEDI-559 (rA2cp248/404/1030ΔSH) at permissive and non-permissive temperatures
- (2012) Jeanne H. Schickli et al. VIRUS RESEARCH
- Follicular Helper CD4 T Cells (TFH)
- (2011) Shane Crotty Annual Review of Immunology
- The many faces of Th17 cells
- (2011) Anneli Peters et al. CURRENT OPINION IN IMMUNOLOGY
- Respiratory syncytial virus vaccine development
- (2011) Julia L Hurwitz Expert Review of Vaccines
- Design and Characterization of Epitope-Scaffold Immunogens That Present the Motavizumab Epitope from Respiratory Syncytial Virus
- (2011) Jason S. McLellan et al. JOURNAL OF MOLECULAR BIOLOGY
- Eosinophils are required for the maintenance of plasma cells in the bone marrow
- (2011) Van Trung Chu et al. NATURE IMMUNOLOGY
- Identification of nucleolin as a cellular receptor for human respiratory syncytial virus
- (2011) Farnoosh Tayyari et al. NATURE MEDICINE
- Phase 1 Study of the Safety and Immunogenicity of a Live, Attenuated Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Vaccine in Seronegative Children
- (2011) David I. Bernstein et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers
- (2011) K. A. Swanson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands
- (2011) Muhammad Shafique et al. VACCINE
- Sendai virus-based RSV vaccine protects African green monkeys from RSV infection
- (2011) Bart G. Jones et al. VACCINE
- Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years
- (2011) Peter L. Collins et al. VIRUS RESEARCH
- A phase 2, randomized, double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season
- (2010) Pilar Fernández et al. BMC Pediatrics
- New insights for development of a safe and protective RSV vaccine
- (2010) Jorge C. G. Blanco et al. Human vaccines & immunotherapeutics
- Smallpox vaccines: targets of protective immunity
- (2010) Bernard Moss IMMUNOLOGICAL REVIEWS
- Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
- (2010) Barney S. Graham IMMUNOLOGICAL REVIEWS
- Efficient Lung Recruitment of Respiratory Syncytial Virus-Specific Th1 Cells Induced by Recombinant Bacillus Calmette-Guerin Promotes Virus Clearance and Protects from Infection
- (2010) K. M. Cautivo et al. JOURNAL OF IMMUNOLOGY
- Transgenic apple expressing an antigenic protein of the human respiratory syncytial virus
- (2010) Joann M. Lau et al. JOURNAL OF PLANT PHYSIOLOGY
- Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins
- (2010) L. W. McGinnes et al. JOURNAL OF VIROLOGY
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
- (2010) Harish Nair et al. LANCET
- A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus
- (2010) J. DeVincenzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation
- (2010) Toon Stegmann et al. VACCINE
- AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats
- (2010) Akihito Sawada et al. VACCINE
- Respiratory viruses and eosinophils: Exploring the connections
- (2009) Helene F. Rosenberg et al. ANTIVIRAL RESEARCH
- Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus
- (2009) R. Kohlmann et al. JOURNAL OF VIROLOGY
- Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology
- (2009) M. R. Murawski et al. JOURNAL OF VIROLOGY
- Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice
- (2009) W. Zhang et al. JOURNAL OF VIROLOGY
- Antibody affinity maturation and respiratory syncytial virus disease
- (2009) Christine A Shaw et al. NATURE MEDICINE
- Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV
- (2009) Bart Jones et al. VACCINE
- Pulmonary Eosinophilia Is Attenuated by Early Responding CD8+ Memory T Cells in a Murine Model of RSV Vaccine-Enhanced Disease
- (2009) Whitney W. Stevens et al. VIRAL IMMUNOLOGY
- Target Peptide Sequence within Infectious Human Immunodeficiency Virus Type 1 Does Not Ensure Envelope-Specific T-Helper Cell Reactivation: Influences of Cysteine Protease and Gamma Interferon-Induced Thiol Reductase Activities
- (2008) R. Sealy et al. Clinical and Vaccine Immunology
- Young Infants Can Develop Protective Levels of Neutralizing Antibody after Infection with Respiratory Syncytial Virus
- (2008) Joshua J. Shinoff et al. JOURNAL OF INFECTIOUS DISEASES
- Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
- (2008) Maria Florencia Delgado et al. NATURE MEDICINE
- Risk Factors for Severe Respiratory Syncytial Virus Disease in Children With Cancer: The Importance of Lymphopenia and Young Age
- (2008) C. M. El Saleeby et al. PEDIATRICS
- Development of a PIV-vectored RSV vaccine: Preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults
- (2008) Roderick S. Tang et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started